The Association Between the Negative Effects Attributed to Ecstasy Use and Measures of Cognition and Mood Among Users

Experimental and Clinical Psychopharmacology

Volumn 17, Issue 5, 2009, Pages 326-336

  Fisk, John E ^a   Montgomery, Catharine ^b   Murphy, Philip N ^c  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c EDGE HILL UNIVERSITY   (United Kingdom)

Author keywords

adverse effects; ecstasy; intelligence; mood

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; AFFECT; ARTICLE; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; FEMALE; HEALTH HAZARD; HUMAN; INTELLIGENCE; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL DISEASE; MENTAL PERFORMANCE; MOOD DISORDER; PARANOIA; SELF CONCEPT; SLEEP PATTERN;

AFFECT; ASSOCIATION LEARNING; COGNITION; EXECUTIVE FUNCTION; FEMALE; HALLUCINOGENS; HUMANS; INTELLIGENCE; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SLEEP; STATISTICS AS TOPIC; SUBSTANCE-RELATED DISORDERS; WAKEFULNESS; YOUNG ADULT;

EID: 70350211881     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0017038     Document Type: Article

References (64)

1. Austin M.P., Mitchell P., and Goodwin G.M. Cognitive deficits in depression: Possible implications for functional neuropathology. British Journal of Psychiatry 178 (2001) 200-206
2. Baylen C.A., and Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction 101 (2006) 933-947
3. Bedi G., and Redman J. Metamemory in recreational ecstasy polydrug users: What do self reports of memory failures mean?. Journal of Psychopharmacology 22 (2008) 872-881
4. Bedi G., Van Dam N.T., and Redman J. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: Somatic anxiety symptoms are associated with polydrug, not ecstasy, use. Journal of Psychopharmacology, Online first (2008) published on October 2nd 2008 as doi: 101177/0269881108097631
5. Broadbent D.E., Cooper P.F., FitzGerald P., and Parkes K.R. The Cognitive Failure Questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology 21 (1982) 1-16
6. Cole J.C., Michailidou K., Jerome L., and Sumnall H.R. The effects of stereotype threat on cognitive function in ecstasy users. Journal of Psychopharmacology 20 (2006) 518-525
7. Craig, L., Fisk, J. E., Montgomery, C., Murphy, P. N., & Wareing, M. (in press). Is emotional intelligence impaired in ecstasy-polydrug users? Journal of Psychopharmacology
8. Croft R.J., Klugman A., Baldeweg T., and Gruzelier J.H. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users. American Journal of Psychiatry 158 (2001) 1687-1692
9. Curran H.V., Rees H., and Hoare T. Empathy and aggression: Two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology 173 (2004) 425-433
10. Curran H.V., and Travill R.A. Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): Weekend 'high' followed by mid-week low. Addiction 92 (1997) 821-831
11. Dafters R.I., Duffy F., and O'Donnell P.J. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in humans correlates with EEG power and coherence. Psychopharmacology 145 (1999) 82-90
12. Falck R.S., Wang J., and Carlson R.G. Depressive symptomatology in young adults with a history of MDMA use: A longitudinal analysis. Journal of Psychopharmacology 22 (2008) 47-54
13. Fisk J.E., and Montgomery C. Real world memory and executive processes in cannabis users and nonusers. Journal of Psychopharmacology 22 (2008) 727-736
14. Fisk J.E., and Sharp C.A. Age-related impairment in executive functioning: Updating, inhibition, shifting, and access. Journal of Clinical and Experimental Neuropsychology 26 (2004) 874-890
15. Fox H.C., McLean A., Turner J.J.D., Parrott A.C., Rogers R., and Sahakian B.J. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users. Psychopharmacology 162 (2002) 203-214
16. 1-sup-5O]-positron emission tomography study. Journal of Clinical Psychopharmacology 21 (2001) 66-71
17. Gilbert D.G., and Gilbert B.O. Personality, psychopathology, and nicotine response as mediators of the genetics of smoking. Behavior Genetics 25 (1995) 133-147
18. Gillberg M., Kecklund G., and Akerstedt T. Relations between performance and subjective ratings of sleepiness during a night awake. Sleep 17 (1994) 236-241
19. Hannon R., Adams P., Harrington S., Fries-Dias C., and Gibson M.T. Effects of brain injury and age on prospective memory self-rating and performance. Rehabilitation Psychology 40 (1995) 289-297
20. Horne J.A., and Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. International Journal Chronobiology 4 (1976) 97-110
21. Hoshi R., Pratt H., and Mehta S. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood- are there gender differences?. Journal of Psychopharmacology 20 (2006) 291-301
22. Johns M., and Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep 20 (1997) 844-849
23. Lamers C.T.J., Bechara A., and Rizzo M. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Journal of Psychopharmacology 20 (2006) 302-311
24. Matthews G., Jones D.M., and Chamberlain G.A. Refining the measurement of mood: The UWIST mood adjective checklist. British Journal of Psychology 81 (1990) 17-42
25. McCardle K., Luebbers S., and Carter J.D. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 173 (2004) 434-439
26. Montgomery C., and Fisk J.E. Everyday memory deficits in ecstasy-polydrug users. Journal of Psychopharmacology 21 (2007) 709-717
27. Montgomery C., Fisk J.E., and Newcombe R. The nature of ecstasy-group related deficits in associative learning. Psychopharmacology 180 (2005) 141-149
28. Montgomery C., Fisk J.E., Newcombe R., and Murphy P.N. The differential effects of ecstasy-polydrug use on executive functions: Shifting, inhibition, updating and access to semantic memory. Psychopharmacology 182 (2005) 262-276
29. Montgomery C., Fisk J.E., Newcombe R., Wareing M., and Murphy P. Syllogistic reasoning performance in MDMA (ecstasy) users. Experimental and Clinical Psychopharmacology 13 (2005) 137-145
30. Montgomery C., Fisk J.E., Wareing M., and Murphy P. Self reported sleep quality and cognitive performance in ecstasy users. Human Psychopharmacology: Clinical and Experimental 22 (2007) 537-548
31. Montoya A.G., Sorrentino R., Lukas S.E., and Price B.H. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): A review. Harvard Review Psychiatry 10 (2002) 212-220
32. Morgan M.J. Recreational use of 'ecstasy' (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19 (1998) 252-264
33. Morgan M.J. Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology 141 (1999) 30-36
34. Morrell H.E.R., and Cohen L.M. Cigarette smoking, anxiety, and depression. Journal of Psychopathology and Behavioral Assessment 28 (2006) 283-297
35. Murphy, P. N., Erwin, P. G., Wareing, M., Blackman, L., Yanulevitch, K., Keane, E., Fisk, J. E., et al. (2008). Time since cannabis use cessation: Implications for mood and IQ performance. Paper presented at the Annual Scientific Meeting of the British Psychological Society Psychobiology Section. http://www.bps.org.uk/psybio/meetings/meetings_home.cfm
36. Murphy P.N., Wareing M., and Fisk J.E. Users' perceptions of the risks and effects of taking MDMA (ecstasy). Journal of Psychopharmacology 20 (2006) 447-455
37. Nelson H.E. National Adult Reading Test (NART) Test manual (1982), NFER-Nelson, Windsor, Berkshire, UK
38. Parrott A.C. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology 173 (2004) 234-241
39. Parrott A.C., Buchanan T., and Scholey A.B. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Human Psychopharmacology: Clinical and Experimental 17 (2002) 309-312
40. Parrott A.C., and Kaye F.J. Daily uplifts, hassles, stresses and cognitive failures: In cigarette smokers, abstaining smokers and non-smokers. Behavioural Pharmacology 10 (1999) 639-646
41. Parrott A.C., and Lasky J. Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a Saturday night dance. Psychopharmacology 139 (1998) 261-268
42. Parrott A.C., Morinan A., Moss M., and Scholey A.B. Understanding Drugs and Behaviour (2004), Wiley, Chichester
43. Parrott A.C., Rodgers J., Buchanan T., Ling J., Heffernan T., and Scholey A.B. Dancing hot on ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. Human Psychopharmacology 21 (2006) 285-298
44. Picciotto M.R., Brunzell D.H., and Caldarone B.J. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport: For Rapid Communication of Neuroscience Research 13 (2002) 1097-1106
45. Pope Jr. H.G. Cannabis, cognition, and residual confounding. Journal of the American Medical Association (JAMA) 287 (2002) 1172-1174
46. Pope Jr. H.G., Gruber A.J., Hudson J.I., Huestis M.A., and Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry 58 (2001) 909-915
47. Ramponi C., Barnard P.J., and Nimmo-Smith I. Recollection deficits in dysphoric mood: An effect of schematic models and executive mode?. Memory 12 (2004) 655-670
48. Raven J., Raven J.C., and Court J.H. Manual for Raven's Progressive Matrices and Vocabulary Scales (1998), Oxford Psychologists Press, Oxford, UK
49. Royle J., and Lincoln N.B. The Everyday Memory Questionnaire-revised: Development of a 13-item scale. Disability and Rehabilitation 30 (2008) 114-121
50. Scheitrum R.R., and Akillas E. Effects of personality style, anxiety and depression on reported reasons for smoking. Journal of Applied Biobehavioral Research 7 (2002) 57-64
51. Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA)-related fatalities. Psychopharmacology 173 (2004) 242-248
52. Scott J.P.R., McNaughton L.R., and Polman R.C.J. Effects of sleep deprivation and exercise on cognitive, motor performance and mood. Physiology and Behavior 87 (2006) 396-408
53. Sedek G., and von Hecker U. Effects of subclinical depression and aging on generative reasoning about linear orders: Same or different processing limitations?. Journal of Experimental Psychology: General 133 (2004) 237-260
54. Selvi Y., Gulec M., Agargun M.Y., and Besiroglu L. Mood changes after sleep deprivation in morningness-eveningness chronotypes in healthy individuals. Journal of Sleep Research 16 (2007) 241-244
55. Solowij N., Hall W., and Lee N. Recreational MDMA use in Sydney: A profile of ecstasy users and their experiences with the drug. British Journal of Addiction 87 (1992) 1161-1172
56. Stewart S.H., Karp J., Pihl R.O., and Peterson R.A. Anxiety sensitivity and self-reported reasons for drug use. Journal of Substance Abuse 9 (1997) 223-240
57. Stough C., Nettelbeck T., Cooper C., and Bates T. Strategy use in Jensen's RT paradigm: Relationships to intelligence?. Australian Journal of Psychology 47 (1995) 1-5
58. Sunderland A., Harris J.E., and Baddeley A.D. Do laboratory tests predict everyday memory?. Journal of Verbal Learning Verbal Behaviour 22 (1983) 341-357
59. Thomasius R., Petersen K., Buchert R., Andresen B., Zapletalova P., Wartberg L., Nebeling B., et al. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167 (2003) 85-96
60. Thomasius R., Zapletalova P., and Petersen K. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: The longitudinal perspective. Journal of Psychopharmacology 20 (2006) 211-225
61. Wallace J.C. Confirmatory factor analysis of the cognitive failures questionnaire: Evidence for dimensionality and construct validity. Personality and Individual Differences 37 (2004) 307-324
62. Wareing M., Fisk J.E., Montgomery C., Murphy P.N., and Chandler M.D. Information processing speed in ecstasy (MDMA) users. Human Psychopharmacology: Clinical and Experimental 22 (2007) 81-88
63. Wareing M., Fisk J.E., and Murphy P.N. Working memory deficits in current and previous users of MDMA (ecstasy). British Journal of Psychology 91 (2000) 181-188
64. Zakzanis K.K., and Young D.A. Memory impairment in abstinent MDMA ("ecstasy") users: A longitudinal investigation. Neurology 56 (2001) 966-969